Konya Training and Research Hospital
Konya, 42090, Turkey (Türkiye)
NCT Number: NCT04290351
In this study, the researchers planned to compare the treatment results of patients undergoing rubber band ligation in addition to drug therapy in hemorrhagic internal hemorrhoids patients and those treated only with anti-hemorrhoidal drugs.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Observational
Konya, 42090, Turkey (Türkiye)
Introduction: Band ligation is one of the most frequently used methods in the treatment of hemorrhagic internal hemorrhoidal disease. Also, phlebotonic use and surgical excision options are available as an anti-hemorrhoidal drug in the treatment of the disease. Many studies have shown that these methods are safe to use. Band ligation is used quite often in our clinic. Whether or not band ligation is performed, these patients are prescribed phlebotonics as an anti-hemorrhoidal drug.
Purpose: In this study, investigators aimed to investigate the benefit of adding rubber band ligation to treatment in hemorrhagic internal hemorrhoidal disease treated with the anti hemorrhoidal drug.
Method: The study was planned prospectively and observationally. Patients are not assigned to groups by the researcher. The researcher cannot interfere with the treatment method given to the patient. The method of treatment is the method approved by the patient's doctor.
Patients diagnosed with internal hemorrhoids will be examined in a group of patients who are prescribed anti-hemorrhoidal drugs and rubber band ligation in the context of routine treatment.
In the other group, again, in the form of routine treatment, patients who are not given rubber band ligation and who are given only anti-hemorrhoidal drugs will be examined.
Group 1: Patients who have been prescribed 450 mg diosmin + 50 mg hesperidin as an anti-hemorrhoidal drug and rubber band ligation will be included in this group.
Group 2: Patients who have been prescribed only 450 mg of diosmin + 50 mg of hesperidin as treatment, without rubber band ligation will be included in this group.
Patients will undergo a control examination in the 21 days after treatment.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Rubber band ligation will be applied to patients, and then phlebotonic will be prescribed.
(Note: The researcher has no contribution or intervention to the treatment method. Patients receiving this treatment will be observed.)
450 mg diosmin + 50 mg hesperidin will be prescribed to patients undergoing band ligation.
(Note: The researcher has no contribution or intervention to the treatment method. Patients receiving this treatment will be observed.)
Time frame: 21 days
At the end of the treatment, the proportion of patients without hemorrhoids bleeding will be calculated.
Time frame: 21 days
It will be determined that the bleeding stops on the day of treatment.
Konya Meram State Hospital
Other
Comparative Study of Band Ligation and Phlebotonic Drug Versus Only Phlebotonic Drug, in Bleeding Internal Hemorrhoids.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04091763
Cardiovascular Diseases, Digestive System Diseases
Porto, Portugal
View Trial DetailsNCT01841970
Cardiovascular Diseases, Digestive System Diseases
Cleveland, Ohio, United States
View Trial DetailsNCT07559630
Cardiovascular Diseases, Digestive System Diseases
Los Angeles, California, United States
View Trial DetailsNCT06878209
Cardiovascular Diseases, Cough
Muğla, Menteşe, Turkey (Türkiye)
View Trial Details